Alzheimer's drug, Biogen's Aduhelm, finds questions, skepticism

Big names like the Cleveland Clinic and Mass General Brigham in Boston say they'll pass on it for now. One neurology practice has even banned Biogen sales reps.

Related Keywords

Rhode Island ,United States ,Boston ,Massachusetts ,Dallas ,Texas ,Washington ,Los Angeles ,Stephen Salloway ,Maha Radhakrishnan ,Brendan Kelley ,Salim Syed ,Wendy Van Fossen ,Neurology Center ,Ut Southwestern Medical Center ,Japan Eisai Co ,Science Department ,Drug Administration ,Cleveland Clinic ,Mass General Brigham ,Mizuho Securities United ,Medical Center ,Van Fossen ,Biogen Chief Medical Officer ,Zaldy Tan ,Medicare Advantage ,Associated Press Health ,Howard Hughes Medical Institute ,